- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2240-2993
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Alzheimer’s disease CSF biomarkers: clinical indications and rational use ; volume:117 ; number:3 ; day:27 ; month:7 ; year:2017 ; pages:591-602 ; date:9.2017
Acta neurologica Belgica ; 117, Heft 3 (27.7.2017), 591-602, 9.2017
- Keyword
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Creator
-
Niemantsverdriet, Ellis
- Contributor
-
Valckx, Sara
Bjerke, Maria
Engelborghs, Sebastiaan
SpringerLink (Online service)
- DOI
-
10.1007/s13760-017-0816-5
- URN
-
urn:nbn:de:1111-201711028015
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Niemantsverdriet, Ellis
- Valckx, Sara
- Bjerke, Maria
- Engelborghs, Sebastiaan
- SpringerLink (Online service)
Other Objects (12)
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease
Bile acid profile associated with CSF and PET biomarkers in Alzheimer’s disease
CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
Cortical folding correlates to aging and Alzheimer’s Disease’s cognitive and CSF biomarkers
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Biomarkers in Alzheimer’s disease
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Dissociation of amyloid biomarkers in PET and CSF in Alzheimer’s disease: a case report
CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease
Author Correction: Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease
Bile acid profile associated with CSF and PET biomarkers in Alzheimer’s disease
CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
Cortical folding correlates to aging and Alzheimer’s Disease’s cognitive and CSF biomarkers
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Biomarkers in Alzheimer’s disease
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Dissociation of amyloid biomarkers in PET and CSF in Alzheimer’s disease: a case report
CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease
Author Correction: Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease
Bile acid profile associated with CSF and PET biomarkers in Alzheimer’s disease
CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
Cortical folding correlates to aging and Alzheimer’s Disease’s cognitive and CSF biomarkers
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Biomarkers in Alzheimer’s disease
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Dissociation of amyloid biomarkers in PET and CSF in Alzheimer’s disease: a case report
CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease